Discounted Cash Flow
NRC Health
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $109.4m | $20.5m | $22.9m | 18.8% | $3.42 |
| 2017 | $117.6m (7.5%) | $22.9m (11.8%) | $23.5m (2.9%) | 19.5% (4.0%) | $3.80 (11.1%) |
| 2018 | $119.7m (1.8%) | $30.0m (31.0%) | $33.9m (44.0%) | 25.1% (28.6%) | $3.47 (-8.7%) |
| 2019 | $128.0m (6.9%) | $32.4m (7.9%) | $36.3m (7.0%) | 25.3% (0.9%) | $2.60 (-25.1%) |
| 2020 | $133.3m (4.1%) | $37.3m (15.0%) | $36.7m (1.1%) | 28.0% (10.4%) | $2.96 (13.8%) |
| 2021 | $148.0m (11.0%) | $37.5m (0.6%) | $40.8m (11.4%) | 25.3% (-9.4%) | $1.47 (-50.3%) |
| 2022 | $151.6m (2.4%) | $31.8m (-15.1%) | $26.4m (-35.3%) | 21.0% (-17.1%) | $1.28 (-12.9%) |
| 2023 | $148.6m (-2.0%) | $31.0m (-2.6%) | $22.3m (-15.5%) | 20.8% (-0.6%) | $1.26 (-1.6%) |
| 2024 | $143.1m (-3.7%) | $24.8m (-20.0%) | $19.2m (-14.1%) | 17.3% (-16.9%) | $1.05 (-16.7%) |
| 2025 | $137.4m (-4.0%) | $11.6m (-53.2%) | $15.7m (-17.9%) | 8.4% (-51.3%) | $50.00 (4661.9%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.